Meeting Neurodegenerative Disease Head-On with Emerging Drug Discovery Strategies

Chronic neurodegenerative diseases encompass a variety of progressive conditions that affect neurons, including Huntington’s disease, Parkinson’s disease, Alzheimer’s disease, and other forms of dementia. They are among the most common and challenging central nervous system (CNS) diseases. “Many companies had stopped their research program into neurodegenerative diseases, but now sophisticated technology advances have became more broadly available” says Kris Rutten, Director at WuXi AppTec. “All of these tools build confidence when developing a drug candidate and are paving a new way of doing CNS drug development.”



WuXi AppTec - Meeting Neurodegenerative Disease Head-On with Emerging Drug Discovery Strategies

Download

← Return to Resources

Related Content

At this year’s annual meeting of the American Association for Cancer Research (AACR), WuXi Biology has been selected to present...

VIEW RESOURCE

WuXi Biology offers an integrated package of preclinical cancer pharmacology services for targeted oncology and immuno-oncology.  Our platform includes in...

VIEW RESOURCE
← View all Biomarkers Resources
× peptide, amino acid

Contact An Expert Today!